Basis Medical
Atlanta, US · Founded 2017 · Delaware LLC
Find your way into Basis Medical
Sign up to see every warm intro you have to Basis Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Basis Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Basis Medical develops the Seclusion catheter and procedure for treating chronic venous insufficiency (CVI), a vein reflux disease affecting the legs. The medical device targets endovenous vein ablation procedures performed at US hospitals and vein centers as an alternative to vein stripping, sclerotherapy, and thermal ablation treatments.
Founders & leadership
KH
Kenneth HarperNamed on SEC filing
DA
David A. MartinNamed on SEC filing
LT
Larry TedescoNamed on SEC filing
TP
Timothy Patrick SharkeyNamed on SEC filing
DC
Darrell CaudillNamed on SEC filing
TL
Tomas Levinton
Reported raises · per SEC filings
Form D private placements$890K disclosed across 3 rounds · 2018–2022
▶$120KraisedDec 2022 · 2 investors · Other Health CareRule 506(b)
▶$120KraisedDec 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ken SmithDirector
- David MartinExecutive Officer, Director
- Darrell CaudillDirector
- David KennedyDirector
- Larry TedescoExecutive Officer
- Robert MathenyDirector
- Offering amount
- $500K
- Amount sold
- $120K
- Minimum investment
- $2.5K
- First sale
- Dec 2022
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$670KraisedSep 2022 · 3 investors · Other Health CareRule 506(b)
▶$670KraisedSep 2022 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David MartinExecutive Officer, Director
- Offering amount
- $670K
- Amount sold
- $670K
- First sale
- Aug 2022
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$100KraisedApr 2018 · 2 investors · Other Health CareRule 506(b)
▶$100KraisedApr 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kenneth HarperDirector
- David A. MartinExecutive Officer, Director
- Larry TedescoExecutive Officer, Director
- Timothy Patrick SharkeyExecutive Officer, Director
- Darrell CaudillExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $100K
- Minimum investment
- $50K
- Proceeds to insiders
- $225K
- First sale
- Apr 2018
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Basis Medical do?
- Basis Medical develops the Seclusion catheter and procedure for treating chronic venous insufficiency (CVI), a vein reflux disease affecting the legs. The medical device targets endovenous vein ablation procedures performed at US hospitals and vein centers as an alternative to vein stripping, sclerotherapy, and thermal ablation treatments.
- How much funding has Basis Medical raised?
- Basis Medical has disclosed $890K raised across 3 rounds.
- Where is Basis Medical headquartered?
- Basis Medical is headquartered in Atlanta, US.